Sodium (4S,12aR)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate
| Product Name |
Sodium (4S,12aR)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate
|
| Product Code |
DA-D249-37
|
| Chemical name |
Sodium (4S,12aR)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate
|
| Synonyms |
3,4,6,8,12,12a-Hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate, sodium (4S,12aR)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-; Enantiomer (IP) Impurity; Sodium (4S,12aR)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate;
|
| Impurity |
NA
|
| CAS Number |
1309575-43-6
|
| Alternate CAS # |
NA
|
| Molecular form |
C20H18F2N3NaO5
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
441.37
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
pharmaceutical standards,impurities,metabolites,Fine Chemicals
|
| Boiling Point |
NA
|
| Applications |
NA
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
